A phase I trial of the CDK 4/6 inhibitor palbociclibin pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)

David Van Mater*, Sridharan Gururangan, Oren Becher, Olivia Campagne, Sarah Leary, Joanna J. Phillips, Jie Huang, Tong Lin, Tina Young Poussaint, Stewart Goldman, Patricia Baxter, Girish Dhall, Giles Robinson, Mariko DeWire-Schottmiller, Eugene I. Hwang, Clinton F. Stewart, Arzu Onar-Thomas, Ira J. Dunkel, Maryam Fouladi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of the CDK 4/6 inhibitor palbociclibin pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science